Kezar Life Sciences Stock Shares Outstanding
| KZR Stock | USD 5.89 0.31 5.56% |
Kezar Life Sciences fundamentals help investors to digest information that contributes to Kezar Life's financial success or failures. It also enables traders to predict the movement of Kezar Stock. The fundamental analysis module provides a way to measure Kezar Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kezar Life stock.
Kezar |
Kezar Life Sciences Company Shares Outstanding Analysis
Kezar Life's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Kezar Life Shares Outstanding | 7.3 M |
Most of Kezar Life's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kezar Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Kezar Life Sciences has 7.3 M of shares currently outstending. This is 95.96% lower than that of the Biotechnology sector and 93.17% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 98.72% higher than that of the company.
Kezar Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kezar Life's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kezar Life could also be used in its relative valuation, which is a method of valuing Kezar Life by comparing valuation metrics of similar companies.Kezar Life is currently under evaluation in shares outstanding category among its peers.
Kezar Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | (88.94 M) | ||||
| Shares Outstanding | 7.3 M | ||||
| Shares Owned By Insiders | 11.99 % | ||||
| Shares Owned By Institutions | 62.00 % | ||||
| Number Of Shares Shorted | 120.6 K | ||||
| Price To Earning | (9.34) X | ||||
| Price To Book | 0.32 X | ||||
| Price To Sales | 6.12 X | ||||
| Revenue | 7 M | ||||
| Gross Profit | (72.35 M) | ||||
| EBITDA | (99.25 M) | ||||
| Net Income | (101.87 M) | ||||
| Cash And Equivalents | 306.84 M | ||||
| Cash Per Share | 4.49 X | ||||
| Total Debt | 18.93 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 39.64 X | ||||
| Book Value Per Share | 18.37 X | ||||
| Cash Flow From Operations | (81.64 M) | ||||
| Short Ratio | 1.46 X | ||||
| Earnings Per Share | (13.12) X | ||||
| Target Price | 13.5 | ||||
| Number Of Employees | 58 | ||||
| Beta | 0.49 | ||||
| Market Capitalization | 40.71 M | ||||
| Total Asset | 221.24 M | ||||
| Retained Earnings | (350.76 M) | ||||
| Working Capital | 189.21 M | ||||
| Current Asset | 74.47 M | ||||
| Current Liabilities | 2.18 M | ||||
| Net Asset | 221.24 M |
About Kezar Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kezar Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kezar Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kezar Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Kezar Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.Moving together with Kezar Stock
Moving against Kezar Stock
The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.
The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.